KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLong-Term Debt IssuancesLong-Term Debt RepaymentsR&D In ProcessShares IssuedShares OutstandingShares RepurchasedShort-Term Debt issuances
Ratios

AbbVie (ABBV) Long-Term Debt Repayments (2016 - 2025)

Historic Long-Term Debt Repayments for AbbVie (ABBV) over the last 11 years, with Q3 2025 value amounting to $9.0 million.

  • AbbVie's Long-Term Debt Repayments fell 9776.67% to $9.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.6 billion, marking a year-over-year increase of 12233.84%. This contributed to the annual value of $9.6 billion for FY2024, which is 13169.44% up from last year.
  • Latest data reveals that AbbVie reported Long-Term Debt Repayments of $9.0 million as of Q3 2025, which was down 9776.67% from $3.8 billion recorded in Q2 2025.
  • In the past 5 years, AbbVie's Long-Term Debt Repayments registered a high of $6.9 billion during Q4 2022, and its lowest value of $2.0 million during Q2 2022.
  • For the 5-year period, AbbVie's Long-Term Debt Repayments averaged around $2.5 billion, with its median value being $2.5 billion (2021).
  • Its Long-Term Debt Repayments has fluctuated over the past 5 years, first crashed by 9994.22% in 2022, then skyrocketed by 5000000.0% in 2023.
  • Quarter analysis of 5 years shows AbbVie's Long-Term Debt Repayments stood at $3.8 billion in 2021, then skyrocketed by 82.6% to $6.9 billion in 2022, then plummeted by 73.81% to $1.8 billion in 2023, then soared by 221.18% to $5.8 billion in 2024, then crashed by 99.84% to $9.0 million in 2025.
  • Its Long-Term Debt Repayments was $9.0 million in Q3 2025, compared to $3.8 billion in Q2 2025 and $3.0 billion in Q1 2025.